VT-362

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVT-362
Drug Alias NameCD30 homologue (Viron)VT-362
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor receptor superfamily member 8 inhibitors
TargetsTumor necrosis factor receptor superfamily member 8
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A